Paxman, the global leader in cancer side effect management, today announced that the American Medical Association (AMA) CPT Editorial Panel has established three Category III CPT® codes describing the ...
Plasma brain-derived tau is emerging as a sensitive biomarker for Alzheimer’s disease and acute neurological disorders, ...